GeoVax Labs Inc. (NASDAQ: GOVX)
$2.96
+0.1500 ( +5.34% ) 4.0M
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy againstĀ head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.
Market Data
Open
$2.96
Previous close
$2.81
Volume
4.0M
Market cap
$7.48M
Day range
$2.82 - $3.55
52 week range
$1.09 - $10.24
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Dec 04, 2023 |
def | Proxies and info statements | 2 | Nov 27, 2023 |
pre | Proxies and info statements | 1 | Nov 17, 2023 |
8-k | 8K-related | 15 | Nov 09, 2023 |
10-q | Quarterly Reports | 41 | Nov 08, 2023 |
4 | Insider transactions | 1 | Sep 27, 2023 |
4 | Insider transactions | 1 | Aug 28, 2023 |
4 | Insider transactions | 1 | Aug 21, 2023 |
4 | Insider transactions | 1 | Aug 14, 2023 |
4 | Insider transactions | 1 | Aug 14, 2023 |